In this secondary study of an open-label , @-week , randomized , controlled trial conducted between April @ and August @ , clinically stable patients with schizophrenia ( DSM-IV ) treated with risperidone or olanzapine were randomly assigned to the reduction group ( dose reduced by @ % ) or maintenance group ( dose kept constant ) .